Wells Fargo’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Wells Fargo's VRTX Position: Q2 2026 in Review
Wells Fargo increased its Vertex Pharmaceuticals (VRTX) stake by 0.61% in Q2 2026, buying an estimated $2.01M and bringing the position to 749,528 shares worth $372M. The position accounts for 0.06% of the portfolio, ranked #269.
Wells Fargo first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $443M in Q2 2020. 1,756 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Wells Fargo held 749,528 shares of Vertex Pharmaceuticals worth $372M as of Q2 2026.
- Wells Fargo bought 4,533 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.01M.
- Vertex Pharmaceuticals made up 0.06% of Wells Fargo's portfolio in Q2 2026, its #269 holding.
- Wells Fargo first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Vertex Pharmaceuticals position peaked at $443M in Q2 2020.
- 1,756 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.